NGIO’s partners are paying for the all of of development now, but yes it’s amazing the contrast. GNBT/NGIO has done a proof of concept on their own to attract and contract with the partners they have to pay for it. They have literally gone to far reaching areas of the earth to provide what will become at minimum a successful booster that currently no one has, and/or a successful vaccine with long term memory that again no one else has.
Let’s let that digest.....Well done GNBT/NGIO!
We are ahead of small companies in our similar situation and our science is robust. We have much to look forward to. It will be interesting how they decide to get the news out as it will no doubt be worthy of publicity in the mainstream.
(10)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links